Urothelial Carcinoma of the Bladder Induces Endothelial Cell Activation and Hypercoagulation
- 30 June 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 18 (7), 1099-1109
- https://doi.org/10.1158/1541-7786.MCR-19-1041
Abstract
Cancer-related venous thromboembolisms (VIE) are associated with metastasis and reduced survival in patients with urothelial cancer of the bladder. Although previous reports suggest the contribution of tissue factor and podoplanin, the mechanistic linkage between VTE and bladder cancer cell-derived molecules is unknown. Therefore, we compared distinct procoagulant pathways in four different cell lines. In vitro findings were further confirmed by microfluidic experiments mimicking the pathophysiology of tumor blood vessels and in tissue samples of patients with bladder cancer by transcriptome analysis and immunohistology. In vitro and microfluidic experiments identified bladder cancer-derived VEGF-A as highly procoagulant because it promoted the release of von Willebrand factor (VWF) from endothelial cells and thus platelet aggregation. In tissue sections from patients with bladder cancer, we found that VWF-mediated blood vessel occlusions were associated with a poor outcome. Transcriptome data further indicate that elevated expression levels of enzymes modulating VEGF-A availability were significantly connected to a decreased survival in patients with bladder cancer. In comparison with previously postulated molecular players, we identified tumor cell-derived VEGF-A and endothelial VWF as procoagulant mediators in bladder cancer. Therapeutic strategies that prevent the VEGF-A-mediated release of VWF may reduce tumor-associated hypercoagulation and metastasis in patients with bladder cancer.Other Versions
Funding Information
- Deutsche Gesellschaft für Urologie (JoA1/FE-16)
This publication has 65 references indexed in Scilit:
- Tumor-derived tissue factor–positive microparticles and venous thrombosis in cancer patientsBlood, 2013
- Activation of blood coagulation in cancer: implications for tumour progressionBioscience Reports, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Local Elongation of Endothelial Cell-anchored von Willebrand Factor Strings Precedes ADAMTS13 Protein-mediated ProteolysisOnline Journal of Public Health Informatics, 2011
- Endothelial von Willebrand factor regulates angiogenesisBlood, 2011
- Deadly allies: the fatal interplay between platelets and metastasizing cancer cellsBlood, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancerMolecular Cancer, 2010
- Shear-induced unfolding triggers adhesion of von Willebrand factor fibersProceedings of the National Academy of Sciences of the United States of America, 2007